Discovering Podophyllotoxin Derivatives as Potential Anti‐Tubulin Agents: Design, Synthesis and Biological Evaluation

[1]  L. Shen,et al.  Etoposide and cisplatin versus irinotecan and cisplatin as the first‐line therapy for patients with advanced, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma: A randomized phase 2 study , 2020, Cancer.

[2]  Weiliang Zhu,et al.  A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib. , 2020, Cancer letters.

[3]  A. Ashworth,et al.  Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy. , 2020, Cancer discovery.

[4]  P. Knochel,et al.  Functionalization of 1,3,4-Oxadiazoles and 1,2,4-Triazoles via Selective Zincation or Magnesiation Using 2,2,6,6-Tetramethylpiperidyl Bases. , 2020, Organic letters.

[5]  Yan Ma,et al.  Curative effect of methotrexate combined with teniposide in the treatment of primary central nervous system lymphoma , 2020, Oncology letters.

[6]  Gang Wang,et al.  SOX7 is involved in polyphyllin D-induced G0/G1 cell cycle arrest through down-regulation of cyclin D1 , 2020, Acta pharmaceutica.

[7]  X. Qi,et al.  IRS1/PI3K/AKT pathway signal involved in the regulation of glycolipid metabolic abnormalities by Mulberry (Morus alba L.) leaf extracts in 3T3-L1 adipocytes , 2020, Chinese Medicine.

[8]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[9]  A. Eriksson,et al.  Simulation-Based Cost Analysis of Industrial Supply of Chips from Logging Residues and Small-Diameter Trees , 2019, Forests.

[10]  Shravankumar Kankala,et al.  Synthesis of d-ring modified acid hydrazide derivatives of podophyllotoxin and their anticancer studies as Tubulin inhibiting agents. , 2019, Bioorganic chemistry.

[11]  Ahmedin Jemal,et al.  Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[12]  A. Kamal,et al.  Design and synthesis of 4β-Acetamidobenzofuranone-podophyllotoxin hybrids and their anti-cancer evaluation. , 2019, Bioorganic & medicinal chemistry letters.

[13]  Guangjun Zhang,et al.  Chondroitin sulfate modification enhances the targeting and therapeutic effect of nanomedicine on AOM/DSS-induced mouse colon cancer , 2019, Journal of Drug Delivery Science and Technology.

[14]  Z. Ding,et al.  Design, Synthesis, and Biological Evaluation of Novel Biotinylated Podophyllotoxin Derivatives as Potential Antitumor Agents , 2019, Front. Chem..

[15]  J. Watanabe,et al.  Cyclin A is a reliable proliferation marker in endometrial cancer cell lines , 2019, Oncology letters.

[16]  M. Faheem.  COMPUTATIONAL AND PHARMACOLOGICAL EVALUATION OF HETEROCYCLIC 1,3,4-OXADIAZOLE AND PYRAZOLES NOVEL DERIVATIVES FOR TOXICITY ASSESSMENT, TUMOUR INHIBITION, ANTIOXIDANT, ANALGESIC AND ANTI-INFLAMMATORY ACTIONS , 2018, FARMACIA.

[17]  K. Tsai,et al.  MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1 , 2018, AntiCancer Research.

[18]  K. Ayub,et al.  Synthesis, structural studies and biological activities of three new 2-(pentadecylthio)-5-aryl-1,3,4-oxadiazoles , 2017 .

[19]  G. Lin,et al.  Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy. , 2016, International journal of pharmaceutics.

[20]  C. Potamitis,et al.  Synthesis and anticancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives , 2016, Arabian Journal of Chemistry.

[21]  N. Gokhale,et al.  Indole-3-carbinol and 1,3,4-Oxadiazole Hybrids: Synthesis and Study of Anti-Proliferative and Anti-Microbial Activity , 2015 .

[22]  R. Sreenivasulu,et al.  Synthesis, cytotoxic activity and docking studies of new 4-aza-podophyllotoxin derivatives , 2015, Medicinal Chemistry Research.

[23]  Dong‐sheng Li,et al.  A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation. , 2014, Bioorganic & medicinal chemistry.

[24]  Jigar A. Makawana,et al.  1,3,4-oxadiazole derivatives as potential biological agents. , 2013, Mini reviews in medicinal chemistry.

[25]  Y. Geng,et al.  Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors. , 2012, European journal of medicinal chemistry.

[26]  Jonas Boström,et al.  Oxadiazoles in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[27]  N. H. Nagoor,et al.  Correction: Regulation of Apoptotic Effects by Erythrocarpine E, a Cytotoxic Limonoid from Chisocheton erythrocarpus in HSC-4 Human Oral Cancer Cells , 2011, PLoS ONE.

[28]  S. Malhotra,et al.  Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin. , 2011, Current medicinal chemistry.

[29]  Joshua E. Elias,et al.  A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers , 2011, Nature.

[30]  Stephen E. Jones.  Metastatic breast cancer: the treatment challenge. , 2008, Clinical breast cancer.

[31]  Jianping Lin,et al.  Synthesis of Triazole‐Epothilones by Using Cu2O Nanoparticles to Catalyze 1,3‐Dipolar Cycloaddition , 2012 .